Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.95 - $27.04 $75,258 - $120,057
4,440 Added 12.71%
39,372 $1.06 Million
Q1 2024

May 15, 2024

BUY
$11.38 - $19.03 $170,085 - $284,422
14,946 Added 74.78%
34,932 $639,000
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $654 - $1,634
104 Added 0.52%
19,986 $245,000
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $75,789 - $165,078
5,056 Added 34.1%
19,882 $298,000
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $78,447 - $121,625
2,636 Added 21.62%
14,826 $481,000
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $464,317 - $704,460
12,190 New
12,190 $476,000
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $296,590 - $464,724
-7,543 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$44.0 - $65.8 $56,408 - $84,355
1,282 Added 20.48%
7,543 $415,000
Q1 2021

May 17, 2021

SELL
$46.31 - $62.7 $5.19 Million - $7.03 Million
-112,121 Reduced 94.71%
6,261 $317,000
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $36,303 - $45,740
654 Added 0.56%
118,382 $7.46 Million
Q3 2020

Nov 16, 2020

SELL
$42.19 - $69.61 $139,184 - $229,643
-3,299 Reduced 2.73%
117,728 $7.91 Million
Q2 2020

Aug 14, 2020

BUY
$27.55 - $43.28 $1.12 Million - $1.76 Million
40,595 Added 50.47%
121,027 $5.07 Million
Q1 2020

May 15, 2020

SELL
$23.16 - $47.8 $1.21 Million - $2.5 Million
-52,248 Reduced 39.38%
80,432 $2.53 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $1.6 Million - $2.31 Million
57,175 Added 75.72%
132,680 $5.36 Million
Q3 2019

Nov 14, 2019

BUY
$31.65 - $46.94 $480,605 - $712,783
15,185 Added 25.17%
75,505 $2.46 Million
Q2 2019

Aug 13, 2019

BUY
$32.5 - $49.12 $1.96 Million - $2.96 Million
60,320 New
60,320 $2.92 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.